3,888 Shares in iRhythm Technologies, Inc. (NASDAQ:IRTC) Acquired by Captrust Financial Advisors

Captrust Financial Advisors acquired a new position in iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 3,888 shares of the company's stock, valued at approximately $351,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Ameriprise Financial Inc. lifted its holdings in iRhythm Technologies by 13.6% in the 4th quarter. Ameriprise Financial Inc. now owns 71,254 shares of the company's stock worth $6,425,000 after buying an additional 8,528 shares in the last quarter. Algert Global LLC lifted its holdings in iRhythm Technologies by 44.9% in the 4th quarter. Algert Global LLC now owns 19,643 shares of the company's stock worth $1,771,000 after buying an additional 6,083 shares in the last quarter. Ancora Advisors LLC raised its stake in shares of iRhythm Technologies by 20.1% in the 4th quarter. Ancora Advisors LLC now owns 4,000 shares of the company's stock valued at $361,000 after purchasing an additional 670 shares in the last quarter. Freestone Grove Partners LP acquired a new stake in shares of iRhythm Technologies in the 4th quarter valued at about $1,507,000. Finally, Comerica Bank raised its stake in shares of iRhythm Technologies by 92.6% in the 4th quarter. Comerica Bank now owns 74,210 shares of the company's stock valued at $6,692,000 after purchasing an additional 35,687 shares in the last quarter.

iRhythm Technologies Stock Performance

IRTC traded up $0.25 on Monday, hitting $142.69. 346,959 shares of the company's stock were exchanged, compared to its average volume of 476,703. The firm has a market cap of $4.56 billion, a PE ratio of -39.20 and a beta of 1.34. iRhythm Technologies, Inc. has a twelve month low of $55.92 and a twelve month high of $144.25. The stock has a fifty day moving average of $115.50 and a two-hundred day moving average of $103.87. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported ($0.95) EPS for the quarter, missing the consensus estimate of ($0.89) by ($0.06). iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. The firm had revenue of $158.68 million during the quarter, compared to the consensus estimate of $153.39 million. During the same quarter last year, the company posted ($1.23) EPS. iRhythm Technologies's revenue for the quarter was up 20.3% on a year-over-year basis. On average, research analysts anticipate that iRhythm Technologies, Inc. will post -1.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company upgraded shares of iRhythm Technologies from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $104.00 to $130.00 in a research note on Friday, May 2nd. Wall Street Zen lowered shares of iRhythm Technologies from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. The Goldman Sachs Group upped their target price on shares of iRhythm Technologies from $91.00 to $124.00 and gave the company a "neutral" rating in a research note on Monday, February 24th. Canaccord Genuity Group cut their target price on shares of iRhythm Technologies from $152.00 to $139.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Finally, Robert W. Baird upped their target price on shares of iRhythm Technologies from $133.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $133.73.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.